The exact medication matters
Some GLP-1 medicines have specific warnings about oral hormonal contraceptives. It is incorrect to say that tirzepatide has no significant effect on birth control pill absorption or that vomiting is the only concern.
Zepbound (tirzepatide) and Foundayo (orforglipron) have different temporary precautions after starting treatment and after dose increases. Ozempic (injectable semaglutide) does not carry those same backup intervals in its prescribing information.
This page summarizes the cited labels. It does not replace a contraceptive consultation or cover every GLP-1 product and formulation.
Label precautions for oral contraception
| Product | What its prescribing information says |
|---|---|
| Zepbound (tirzepatide) | Switch to a non-oral contraceptive method or add a barrier method for 4 weeks after treatment starts and for 4 weeks after every dose increase. |
| Foundayo (orforglipron) | Switch to a non-oral contraceptive method or add a barrier method for 30 days after treatment starts and for 30 days after every dose increase. |
| Ozempic (injectable semaglutide) | Clinical pharmacology studies did not show a clinically relevant interaction with the studied oral contraceptive. The label still advises caution with oral medicines because gastric emptying is delayed. It does not specify the same backup intervals as Zepbound or Foundayo. |
Sources: Zepbound sections 7.2 and 8.3, Foundayo sections 7.3 and 8.3, and Ozempic sections 7.2 and 12.3, accessed September 13, 2026.
The Zepbound and Foundayo labels state that hormonal contraceptives not taken by mouth should not be affected. The suitability of an IUD, implant, patch, ring, injection, or other method still depends on your health and preferences. A clinician can help you choose; do not stop your current contraception without a plan.
Vomiting, diarrhea, and missed pills need separate advice
Even without a product-specific interaction, vomiting or diarrhea can complicate oral contraceptive use. The response depends on the type of pill, the timing, and how long symptoms last. NHS guidance gives separate instructions for the combined pill and the progestogen-only pill. A single rule such as “use backup for seven days” does not cover every contraceptive.
Follow your pill's instructions for missed doses or illness and contact a pharmacist if you are unsure. If you have had sex during a possible gap in protection, ask promptly whether emergency contraception is appropriate; options are time-sensitive. Do not wait for the next GLP-1 appointment to ask.
Pregnancy and planning ahead
GLP-1 treatment is not contraception. If you think you may be pregnant, contact your prescriber promptly. The Zepbound and Foundayo labels (section 8.1) say to discontinue treatment when pregnancy is recognized. Your clinician should review your medicines and ongoing care.
Before trying to conceive, arrange a medication review rather than using a class-wide stopping interval. The Ozempic label (section 8.3) specifies stopping at least 2 months before a planned pregnancy because semaglutide takes time to clear. That interval should not be copied to every GLP-1 medicine. Your prescriber should plan any treatment changes, including diabetes care if applicable.
Before starting or increasing treatment
Bring the names of both your GLP-1 medicine and your contraceptive to your prescriber or pharmacist. Ask:
- Whether the exact product has an oral-contraceptive warning.
- Which backup or non-oral method fits your circumstances and when it is needed.
- What to do if vomiting, diarrhea, or missed pills occur.
- Who to contact if pregnancy is possible or you want to plan a pregnancy.
This is a medication review, not a reason to change GLP-1 doses yourself. For insulin, statins, supplements, and other medicines, see our GLP-1 interaction checklist.
This article is educational and is not personal medical advice. Your prescriber determines your treatment plan; your pharmacist can help reconcile medication instructions.
